Research & Development

天天啪影院天天啪在线视频青青草av湖北5G三年计划:力争2021年核心产业产值超2000亿

發布時間︰

  褚狼走進雲瑯書房的時候,霍光正坐在一張椅子上看書,張安世跪坐在毯子上整理一些卷軸。   雲瑯點點頭道︰“以前听一位高人說過,一個人的本事一定要跟一個人的心性修養相匹配。天天啪影院   廚娘匆匆的去準備了。天天啪在线视频   張安世見四周無人,就把嘴巴湊到霍光耳邊道︰“要不,我帶你去趟春風樓?”   雲瑯打橫把甦稚抱起來,剛剛出了月子的女人總是這樣折磨自己,對身體的傷害實在太大。青青草av   “有什麼不妥的?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.


Connect? Registries


The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo